Rexel

21/11/22 -"The increase in our EPS estimate is attributable to the upgraded FY22 guidance, which includes: 1) same-day sales growth of c.12% (vs 7-9% previously), and 2) an adjusted EBITA margin of c. 7.2% (vs ..."

PDF page sample
Pages
47
Language
English
Published on
21/11/22
Download
You may also be interested by these reports :
29/03/23
The outlook for the German online pharmacy market in 2023E is positive. Zur Rose G. lost market share in 2022
29/03/23
The divestment of group’s Swiss business will delay the way to adj. EBITDA profitability; Add confirmed but lower TP
23/03/23
We now take a more conservative view on Currys’ performance in the Nordics segment (c.40% of group revenue and c.47% operating profit in FY21/22). ...
23/03/23
FY23E: Sales to decline yoy, adj. EBITDA break-even postponed to FY24E

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO